CII vs AIMED: There has been mistrust between the medical devices companies and patients on the pricing issue
"Nothing can be further from truth. CII's assertions is absolutely unfounded, misleading and totally against PM Modi's vision of ‘Make in India'," said Mr Rajiv Nath, Forum Coordinator of Association of Indian Medical Device Industry (AIMED), the largest industry body of medical device manufacturers in India.
AIMED has strongly refuted the assertions made by CII that raising import duty will hurt consumers' interest and would be detrimental to Indian medical device industry or Indian consumers.
Mr Nath in a statement said that he was rather aghast that a respected industry body like CII has permitted itself to be misused by groups who are inimical to country's long term interests and did not want domestic manufacturing to take off in India.
He further pointed out that duty rationalization by lowering the duty on raw materials and increasing it on finished devices will not only create a level playing field between imports and domestically manufactured goods but will also give the much needed impetus to domestic manufacturing. He added that duty rationalization will also attract MNCs to set up manufacturing units within the country rather than continuing with their preferred route of imports to market their products in India.
"If government really wants to realize the PM's vision of ‘Make in India', it needs to correct the flawed legacy duty structure which made us an import dependent nation in the critical sector of medical devices," said Mr Nath.